TransCom Global Ltd   Report issue

For profit Phase 2
Founded: Manchester United Kingdom (1998)

Organization Overview

First Clinical Trial
2011
NCT01429519
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

TransCom Global Ltd. (CRO)